RIGEL PHARMACEUTICALS INC (RIGLXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$1
Reported value
0.0%
Held as options
-8
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $1 | 1 | 0.00% | 11q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $1 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 9 | $99.4K | 3,664 | 1 | 4 | 4 | 0.0% |
| Q4 2025 | 9 | $2.0M | 45,985 | 5 | 3 | 0 | 0.0% |
| Q3 2025 | 5 | $929.3K | 32,802 | 2 | 1 | 0 | 0.0% |
| Q2 2025 | 4 | $18.0K | 960 | 0 | 2 | 0 | 0.0% |
| Q1 2025 | 5 | $15.9K | 918 | 1 | 3 | 0 | 0.0% |
| Q4 2024 | 5 | $20.4K | 1,211 | 2 | 0 | 0 | 0.0% |
| Q3 2024 | 4 | $11.8K | 733 | 1 | 0 | 0 | 0.0% |
| Q2 2024 | 8 | $90.1K | 11,725 | 2 | 0 | 5 | 0.0% |
| Q1 2024 | 105 | $194.3M | 130,716,508 | 10 | 33 | 31 | 0.4% |
| Q4 2023 | 100 | $165.1M | 113,214,442 | 14 | 34 | 20 | 0.6% |
| Q3 2023 | 95 | $107.6M | 98,997,737 | 5 | 24 | 32 | 0.6% |
| Q2 2023 | 104 | $132.5M | 102,087,997 | 5 | 28 | 38 | 0.6% |
| Q1 2023 | 104 | $131.2M | 98,941,955 | 16 | 27 | 32 | 0.4% |
| Q4 2022 | 92 | $137.7M | 91,379,411 | 10 | 28 | 30 | 0.5% |
| Q3 2022 | 135 | $150.8M | 127,918,221 | 22 | 40 | 32 | 0.3% |
| Q2 2022 | 132 | $158.6M | 139,150,385 | 9 | 32 | 46 | 0.8% |
| Q1 2022 | 162 | $407.0M | 135,361,823 | 17 | 44 | 54 | 0.3% |
| Q4 2021 | 157 | $369.6M | 138,799,612 | 19 | 43 | 50 | 0.5% |
| Q3 2021 | 160 | $503.9M | 137,594,726 | 15 | 54 | 42 | 0.8% |
| Q2 2021 | 158 | $619.9M | 141,590,454 | 25 | 42 | 48 | 0.9% |
| Q1 2021 | 149 | $496.1M | 144,193,470 | 24 | 39 | 54 | 0.6% |
| Q4 2020 | 147 | $504.8M | 142,976,843 | 19 | 43 | 48 | 0.9% |
| Q3 2020 | 139 | $337.8M | 139,767,523 | 23 | 33 | 49 | 0.7% |
| Q2 2020 | 134 | $265.3M | 144,942,289 | 19 | 47 | 32 | 0.0% |
| Q1 2020 | 122 | $234.6M | 149,516,487 | 7 | 30 | 45 | 0.0% |
| Q4 2019 | 131 | $321.1M | 150,249,889 | 17 | 45 | 35 | 0.0% |
| Q3 2019 | 128 | $276.0M | 147,545,240 | 17 | 36 | 35 | 0.0% |
| Q2 2019 | 124 | $418.1M | 156,475,539 | 11 | 44 | 28 | 0.6% |
| Q1 2019 | 128 | $403.4M | 156,739,121 | 14 | 35 | 29 | 0.2% |
| Q4 2018 | 129 | $370.9M | 160,515,741 | 4 | 2 | 2 | 0.5% |